nach oben

19.01.2024 | case report

Intramuscular botulinum toxin-A in complex regional pain syndrome resistant to standard treatment: a case report

verfasst von: Yasemin Tombak, MD, Assoc. Prof. Dr. Ozgur Zeliha Karaahmet, Prof. Dr. Ece Unlu Akyuz

Erschienen in: Wiener klinische Wochenschrift

Einloggen, um Zugang zu erhalten

Summary

Objective

To present a patient with complex regional pain syndrome type 1 (CRPS-I) and improvement of contracture of hand muscles and grip strength after successful treatment with botulinum neurotoxin‑A (BoNT-A).

Case

A 53-year-old woman with CRPS‑I experienced severe allodynia, swelling and autonomic changes in the left hand after a distal radius fracture. Over the succeeding months, she developed contracture of the left hand muscles which was treated with injection of BoNT‑A into the hand muscles (10 points).

Results

In the patient treatment with BoNT‑A an improvement was seen in the hand range of motion (ROM) and grip strength.

Conclusion

Successful results can be obtained with BoNT‑A injection in treatment-resistant CRPS‑I cases which may develop joint contracture.

Petersen PB, Mikkelsen KL, Lauritzen JB, Krogsgaard MR. Risk Factors for Post-treatment Complex Regional Pain Syndrome (CRPS): An Analysis of 647 Cases of CRPS from the Danish Patient Compensation Association. Pain Pract. 2018;18(3):341–9. Mar.CrossRefPubMed

Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med. 2007;8(4):326–31.CrossRefPubMed

Shim H, Rose J, Halle S, Shekane P. Complex regional pain syndrome: a narrative review for the practising clinician. Br J Anaesth. 2019;123(2):e424–e33.CrossRefPubMedPubMedCentral

Kharkar S, Ambady P, Yedatore V, Schwartzman RJ. Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome. Pain Physician. 2011 May-Jun;14(3):311–6.

Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.CrossRefPubMedPubMedCentral

Yuan RY, Sheu JJ, Yu JM, Chen WT, Tseng IJ, Chang HH, Hu CJ. Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial. Neurology. 2009;72:1473–8.CrossRefPubMed

Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008;64:274–83.CrossRefPubMed

Safarpour D, Jabbari B. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases. Pain Med. 2010;11(9):1415–8. Sep.CrossRefPubMed

Bellon G, Venturin A, Masiero S, Del Felice A. Intra-articular botulinum toxin injection in complex regional pain syndrome: Case report and review of the literature. Toxicon. 2019;1;159:41–4. Mar.CrossRef

10.

Lee Y, Lee CJ, Choi E, Lee PB, Lee HJ, Nahm FS. Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome. Toxins (basel). 2018;19;10(4):164. Apr.CrossRef

11.

Safarpour D, Salardini A, Richardson D, Jabbari B. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study. Pain Med. 2010;11(9):1411–4. Sep.CrossRefPubMed

12.

Birthi P, Sloan P, Salles S. Subcutaneous botulinum toxin A for the treatment of refractory complex regional pain syndrome. PM R. 2012;4(6):446–9. Jun.CrossRefPubMed

13.

Kwak H, Koh J, Min K. Botulinum Toxin Treatment for Intractable Allodynia in a Patient with Complex Regional Pain Syndrome: A Case Report. Neurol Asia. 2020;25:215–9.

14.

Tereshko Y, Dalla Torre C, Lettieri C, Belgrado E, Gigli GL, Valente M. Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report. Toxins (Basel). 2022 Jun 16;14(6):411.Error! Hyperlink reference not valid.

15.

Ota H, Arai T, Iwatsuki K, Urano H, Kurahashi T, Kato S, Yamamoto M, Hirata H. Pathological mechanism of musculoskeletal manifestations associated with CRPS type II: an animal study. Pain. 2014;155(10):1976–85. https://doi.org/10.1016/j.pain.2014.06.016.CrossRefPubMed

16.

Honda Y, Tanaka N, Kajiwara Y, Kondo Y, Kataoka H, Sakamoto J, Akimoto R, Nawata A, Okita M. Effect of belt electrode-skeletal muscle electrical stimulation on immobilization-induced muscle fibrosis. PLoS One. 2021 May 13;16(5):e0244120. https://doi.org/10.1371/journal.pone.0244120.

17.

Kim S, Ahn M, Piao Y, Ha Y, Choi DK, Yi MH, et al. Effect of Botulinum Toxin Type A on TGF-β/Smad Pathway Signaling: Implications for Silicone-Induced Capsule Formation. Plast Reconstr Surg. 2016 Nov;138(5):821e–829e. https://doi.org/10.1097/PRS.0000000000002625.

18.

Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens. Neurol Sci. 2005;26:32–9.CrossRefPubMed

Titel: Intramuscular botulinum toxin-A in complex regional pain syndrome resistant to standard treatment: a case report
verfasst von: Yasemin Tombak, MD
Assoc. Prof. Dr. Ozgur Zeliha Karaahmet
Prof. Dr. Ece Unlu Akyuz
Publikationsdatum: 19.01.2024
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-023-02317-x